↓ Skip to main content

Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial

Overview of attention for article published in Trials, August 2022
Altmetric Badge

Mentioned by

news
4 news outlets
twitter
158 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
31 Mendeley